| Stage | CHDN | % of rev | AWI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $696M | 100.00% | $476M | 100.00% | CHDN ×1.46 |
| Gross profit | $207M | 29.74% | $191M | 40.08% | AWI +10.3pp |
| Operating income | $143M | 20.55% | $131M | 27.57% | AWI +7.0pp |
| Pre-tax income | $111M | 15.95% | $124M | 26.15% | AWI +10.2pp |
| Net income | $80M | 11.49% | $92M | 19.31% | AWI +7.8pp |
| Stage | CHDN | AWI | Gap · A − B |
|---|---|---|---|
| Revenue | $696M100.00% | $476M100.00% | CHDN ×1.46 |
| Gross profit | 29.74%$207M | 40.08%$191M | AWI +10.3pp |
| Operating income | 20.55%$143M | 27.57%$131M | AWI +7.0pp |
| Pre-tax income | 15.95%$111M | 26.15%$124M | AWI +10.2pp |
| Net income |
| 11.49%$80M |
| 19.31%$92M |
| AWI +7.8pp |
No shared counterparties.